TrialClinical infectious diseases : an official publication of the Infectious Diseases Society of America2025

Phase 1 Evaluation of VH4524184, a Third-Generation Integrase Strand Transfer Inhibitor With an Enhanced Resistance Profile.

Luise Rogg et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.